Aortic Stenosis News and Research

RSS

New heart valve procedure helpful for the elderly: Study

Researchers revealed this Sunday a new heart valve that can be implanted without surgery. The device may hold promise for tens of thousands of elderly patients who might not survive a standard valve-replacement operation.

3 Apr 2011

Two experts to comment on new transcatheter heart valve studies

New transcatheter heart valve studies will be presented at the American College of Cardiology meeting in New Orleans on April 3 and 4. The studies compare patient outcomes from minimally invasive catheter procedures with those from open-heart surgery.

2 Apr 2011

Medtronic's Resolute drug-eluting stent pivotal U.S. data to be presented at ACC.11

Medtronic, Inc., today announced the imminent release of the pivotal U.S. data on its Resolute drug-eluting stent at ACC.11, the 60th Annual Scientific Session & Expo of the American College of Cardiology, which takes place April 2-5 in New Orleans.

29 Mar 2011

Specific inflammatory factor may be responsible for aortic stenosis development

Research from Karolinska Institutet in Sweden shows that a specific inflammatory factor may be important in the development of the heart valve disease aortic stenosis. The results suggest that anti-inflammatory medication could be a possible new treatment.

15 Mar 2011

U-M's CoreValve trial to offer less invasive approach for patients with aortic stenosis

The University of Michigan Cardiovascular Center, a leader in heart valve replacement, will participate in a national clinical trial to offer patients a less invasive approach to replacing diseased aortic valves.

14 Mar 2011

U-M participates in national trial for alternative approach to open heart surgery for severe aortic stenosis

10 Mar 2011

DMC CVI completes the first two transcatheter aortic valve implants in Michigan

The Detroit Medical Center (DMC) Cardiovascular Institute (CVI) has completed the first two transcatheter aortic valve implants (TAVI) ever achieved in Michigan. The procedures are a part of CVI's participation in the Medtronic CoreValve® U.S. Clinical Trial. This multi-state trial will evaluate a new, non-surgical alternative to open-heart surgery for patients with severe aortic stenosis.

2 Mar 2011

Investigational heart valve implanted in patient through small puncture hole in leg

Physicians at the Methodist DeBakey Heart & Vascular Center in Houston implanted a new investigational heart valve in a patient through a small puncture hole in the leg.

21 Feb 2011

Positive results from Medtronic CoreValve System study for treatment of aortic valve disease

Medtronic, Inc. today issued a statement on results from an independent study published online in the journal Circulation, which confirmed both early and sustained clinical benefits for patients receiving the Medtronic CoreValve® System for the treatment of aortic valve disease.

19 Feb 2011

Sorin's 2010 consolidated revenues increase 4.9% to € 745.8 million

The Board of Directors of Sorin S.p.A. meeting today under the chairmanship of Rosario Bifulco reviewed the fourth quarter 2010 and the preliminary 2010 consolidated results.

11 Feb 2011

Sorin Group announces commercial availability of Perceval S aortic heart valve in Europe

Sorin Group, a global medical device company and a leader in the treatment of cardiovascular diseases, announces the commercial availability in Europe of the self- anchoring Perceval S aortic heart valve. The innovative next-generation valve represents the latest innovation in heart valve technology.

31 Jan 2011

Mount Sinai's Cardiac Catheterization Lab wins New York State's highest 'two-star' safety rating

Mount Sinai's Cardiac Catheterization Laboratory has been awarded New York State's highest "two-star" safety rating in every category of case the state tracks for percutaneous coronary intervention, according to new data released this month that examine patient discharges from 2006 - 2008.

27 Jan 2011

LHSC performs complicated aortic valve bypass surgery using Correx AVB device

Doctors at London Health Sciences Centre (LHSC) are the first in the world to use a new implantable surgical device that promises to revolutionize aortic valve bypass surgery.

25 Jan 2011

Methodist DeBakey Heart & Vascular Center chosen for critical percutaneous heart valve study

The Methodist DeBakey Heart & Vascular Center was chosen today as a site for a critical percutaneous heart valve study. As part of the research study, Methodist physicians will replace diseased cardiac valves through a single, tiny puncture hole in the research subject's groin.

24 Jan 2011

First successful transcatheter implantation of 27mm transapical aortic valve prosthesis

JenaValve™ Technology, Inc., a medical device company specializing in developing transcatheter aortic valve implantation (TAVI) systems, announced today a significant clinical milestone: the first-ever successful transcatheter implantation of a 27mm transapical aortic valve prosthesis.

19 Jan 2011

Medtronic recieves conditional approval from FDA to modify CoreValve U.S. Pivotal Clinical Trial

Medtronic, today announced it has received conditional approval from the U.S. Food and Drug Administration to modify its CoreValve U.S. Pivotal Clinical Trial.

19 Jan 2011

Cardiac surgery market to reach over $4.4 billion by 2017

According to a new report by iData Research, the leading global authority in medical device and pharmaceutical market research, percutaneous aortic valve replacement (PAVR) and percutaneous mitral valve repair (PMVR) devices are expected to enter the U.S. market in 2011 and grow to almost $1.3 billion by 2017.

18 Jan 2011

Boston Scientific acquires Sadra Medical

Boston Scientific Corporation today announced the completion of its acquisition of Sadra Medical, Inc. of Los Gatos, California. The transaction follows the definitive merger agreement announced on November 19, 2010.

4 Jan 2011

First implantation of Medtronic Transcatheter Aortic Valve Prosthesis in US performed at Mount Sinai

David H. Adams, MD, Marie-Jos-e and Henry R. Kravis Professor and Chairman of the Department of Cardiothoracic Surgery, Samin K. Sharma, MD, the Zena and Michael A. Weiner Professor and Director of the Cardiac Catheterization Laboratory, and Annapoorna S. Kini, MD, Associate Professor and Associate Director of the Cardiac Catheterization Laboratory at The Mount Sinai Medical Center, have performed the first implantation of the Medtronic CoreValve- Transcatheter Aortic Valve Prosthesis in the United States.

22 Dec 2010

U.S. pivotal clinical trial of Medtronic CoreValve begins

Medtronic, Inc. today announced the beginning of its Medtronic CoreValve® U.S. Pivotal clinical trial in the United States. The first CoreValve transcatheter aortic valve implantation (TAVI) procedure was performed by David H. Adams, M.D., and Samin K. Sharma, M.D., at The Mount Sinai Medical Center in New York City.